Boothbay Fund Management, LLC G1 Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.12 - $3.73 $22,618 - $75,327
20,195 New
20,195 $61,000
Q1 2023

May 15, 2023
BUY
$2.57 - $8.16 $28,627 - $90,894
11,139 Added 73.47%
26,300 $70,000
Q4 2022

Feb 14, 2023
BUY
$5.19 - $13.5 $78,685 - $204,673
15,161 New
15,161 $82,000
Q3 2019

Nov 14, 2019
SELL
$22.78 - $40.58 $799,828 - $1.42 Million
-35,111 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$16.03 - $31.1 $562,829 - $1.09 Million
35,111 New
35,111 $1.08 Million

Others Institutions Holding GTHX

# of Institutions
6
Shares Held
3.55M
Call Options Held
11.7K
Put Options Held
0
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email